Notification of Transactions of Directors, Persons Discharging Managerial
Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £12.67 per share on 15 January 2010, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $41.13 per ADR on 15 January 2010, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 7 January 2010.
|
Ordinary shares |
ADRs |
Mr A P Witty |
2.72 |
|
Mr J S Heslop |
0.01 |
|
Dr M M Slaoui |
145.25 |
|
Mrs C E Bruck Slaoui |
29.80 |
|
Mr S M Bicknell |
77.66 |
|
Mr J M Clarke |
152.06 |
|
Mr M Dunoyer |
94.14 |
|
Mr E J Gray |
166.14 |
|
Mr D Learmouth |
45.12 |
|
Mr W C Louv |
|
27.99 |
Mr D J Phelan |
|
141.68 |
Dr D Pulman |
|
81.96 |
Mr D S Redfern |
72.08 |
|
Ms C Thomas |
54.75 |
|
Mr J R Stéphenne |
475.69 |
|
The Company was advised of this information on 18 January 2010.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
19 January 2010